Nicotinamide Phosphoribosyltransferase Industry Research Report 2025
Description
Summary
According to APO Research, the global Nicotinamide Phosphoribosyltransferase market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Nicotinamide Phosphoribosyltransferase include OncoTartis, Inc., Karyopharm Therapeutics, Inc., Genentech, Inc., FORMA Therapeutics, Inc., Calico LLC, Aurigene Discovery Technologies Limited and Angelini Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Phosphoribosyltransferase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Phosphoribosyltransferase.
The report will help the Nicotinamide Phosphoribosyltransferase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Nicotinamide Phosphoribosyltransferase market size, estimations, and forecasts are provided in terms of sales volume (W Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nicotinamide Phosphoribosyltransferase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Nicotinamide Phosphoribosyltransferase Segment by Company
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Genentech, Inc.
FORMA Therapeutics, Inc.
Calico LLC
Aurigene Discovery Technologies Limited
Angelini Group
Nicotinamide Phosphoribosyltransferase Segment by Type
Lipids
Small Molecule Compounds
Hormone
Others
Nicotinamide Phosphoribosyltransferase Segment by Application
Breast Cancer
Parkinson's Disease
Acute Lung Injury
Others
Nicotinamide Phosphoribosyltransferase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Phosphoribosyltransferase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Phosphoribosyltransferase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Phosphoribosyltransferase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicotinamide Phosphoribosyltransferase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicotinamide Phosphoribosyltransferase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Nicotinamide Phosphoribosyltransferase market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Nicotinamide Phosphoribosyltransferase include OncoTartis, Inc., Karyopharm Therapeutics, Inc., Genentech, Inc., FORMA Therapeutics, Inc., Calico LLC, Aurigene Discovery Technologies Limited and Angelini Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Phosphoribosyltransferase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Phosphoribosyltransferase.
The report will help the Nicotinamide Phosphoribosyltransferase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Nicotinamide Phosphoribosyltransferase market size, estimations, and forecasts are provided in terms of sales volume (W Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nicotinamide Phosphoribosyltransferase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Nicotinamide Phosphoribosyltransferase Segment by Company
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Genentech, Inc.
FORMA Therapeutics, Inc.
Calico LLC
Aurigene Discovery Technologies Limited
Angelini Group
Nicotinamide Phosphoribosyltransferase Segment by Type
Lipids
Small Molecule Compounds
Hormone
Others
Nicotinamide Phosphoribosyltransferase Segment by Application
Breast Cancer
Parkinson's Disease
Acute Lung Injury
Others
Nicotinamide Phosphoribosyltransferase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Phosphoribosyltransferase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Phosphoribosyltransferase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Phosphoribosyltransferase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicotinamide Phosphoribosyltransferase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicotinamide Phosphoribosyltransferase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
118 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nicotinamide Phosphoribosyltransferase Market Size (2020-2031)
- 2.2.2 Global Nicotinamide Phosphoribosyltransferase Sales (2020-2031)
- 2.2.3 Global Nicotinamide Phosphoribosyltransferase Market Average Price (2020-2031)
- 2.3 Nicotinamide Phosphoribosyltransferase by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Lipids
- 2.3.3 Small Molecule Compounds
- 2.3.4 Hormone
- 2.3.5 Others
- 2.4 Nicotinamide Phosphoribosyltransferase by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Breast Cancer
- 2.4.3 Parkinson's Disease
- 2.4.4 Acute Lung Injury
- 2.4.5 Others
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nicotinamide Phosphoribosyltransferase Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Nicotinamide Phosphoribosyltransferase Sales (W Tons) of Manufacturers (2020-2025)
- 3.3 Global Nicotinamide Phosphoribosyltransferase Revenue of Manufacturers (2020-2025)
- 3.4 Global Nicotinamide Phosphoribosyltransferase Average Price by Manufacturers (2020-2025)
- 3.5 Global Nicotinamide Phosphoribosyltransferase Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Product Type & Application
- 3.8 Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Established Date
- 3.9 Global Nicotinamide Phosphoribosyltransferase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 OncoTartis, Inc.
- 4.1.1 OncoTartis, Inc. Company Information
- 4.1.2 OncoTartis, Inc. Business Overview
- 4.1.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.1.5 OncoTartis, Inc. Recent Developments
- 4.2 Karyopharm Therapeutics, Inc.
- 4.2.1 Karyopharm Therapeutics, Inc. Company Information
- 4.2.2 Karyopharm Therapeutics, Inc. Business Overview
- 4.2.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.2.5 Karyopharm Therapeutics, Inc. Recent Developments
- 4.3 Genentech, Inc.
- 4.3.1 Genentech, Inc. Company Information
- 4.3.2 Genentech, Inc. Business Overview
- 4.3.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.3.5 Genentech, Inc. Recent Developments
- 4.4 FORMA Therapeutics, Inc.
- 4.4.1 FORMA Therapeutics, Inc. Company Information
- 4.4.2 FORMA Therapeutics, Inc. Business Overview
- 4.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.4.5 FORMA Therapeutics, Inc. Recent Developments
- 4.5 Calico LLC
- 4.5.1 Calico LLC Company Information
- 4.5.2 Calico LLC Business Overview
- 4.5.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.5.5 Calico LLC Recent Developments
- 4.6 Aurigene Discovery Technologies Limited
- 4.6.1 Aurigene Discovery Technologies Limited Company Information
- 4.6.2 Aurigene Discovery Technologies Limited Business Overview
- 4.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.6.5 Aurigene Discovery Technologies Limited Recent Developments
- 4.7 Angelini Group
- 4.7.1 Angelini Group Company Information
- 4.7.2 Angelini Group Business Overview
- 4.7.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
- 4.7.5 Angelini Group Recent Developments
- 5 Global Nicotinamide Phosphoribosyltransferase Market Scenario by Region
- 5.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2020-2031
- 5.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2020-2025
- 5.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2026-2031
- 5.3 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2020-2031
- 5.3.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2020-2025
- 5.3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2026-2031
- 5.4 North America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.4.1 North America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
- 5.4.3 North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.5.1 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
- 5.5.3 Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.7.1 South America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
- 5.7.3 South America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031)
- 6.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031) & (W Tons)
- 6.1.2 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2020-2031)
- 6.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031)
- 6.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2020-2031)
- 6.3 Global Nicotinamide Phosphoribosyltransferase Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031)
- 7.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031) & (W Tons)
- 7.1.2 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2020-2031)
- 7.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031)
- 7.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2020-2031)
- 7.3 Global Nicotinamide Phosphoribosyltransferase Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nicotinamide Phosphoribosyltransferase Value Chain Analysis
- 8.1.1 Nicotinamide Phosphoribosyltransferase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nicotinamide Phosphoribosyltransferase Production Mode & Process
- 8.2 Nicotinamide Phosphoribosyltransferase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nicotinamide Phosphoribosyltransferase Distributors
- 8.2.3 Nicotinamide Phosphoribosyltransferase Customers
- 9 Global Nicotinamide Phosphoribosyltransferase Analyzing Market Dynamics
- 9.1 Nicotinamide Phosphoribosyltransferase Industry Trends
- 9.2 Nicotinamide Phosphoribosyltransferase Industry Drivers
- 9.3 Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges
- 9.4 Nicotinamide Phosphoribosyltransferase Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Nicotinamide Phosphoribosyltransferase Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Nicotinamide Phosphoribosyltransferase Sales (W Tons) of Manufacturers (2020-2025)
- Table 7. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Nicotinamide Phosphoribosyltransferase Revenue of Manufacturers (2020-2025)
- Table 9. Global Nicotinamide Phosphoribosyltransferase Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Nicotinamide Phosphoribosyltransferase Average Price (US$/Ton) of Manufacturers (2020-2025)
- Table 11. Global Nicotinamide Phosphoribosyltransferase Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Product Type & Application
- Table 14. Global Nicotinamide Phosphoribosyltransferase Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Nicotinamide Phosphoribosyltransferase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. OncoTartis, Inc. Company Information
- Table 19. OncoTartis, Inc. Business Overview
- Table 20. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
- Table 21. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- Table 22. OncoTartis, Inc. Recent Developments
- Table 23. Karyopharm Therapeutics, Inc. Company Information
- Table 24. Karyopharm Therapeutics, Inc. Business Overview
- Table 25. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
- Table 26. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- Table 27. Karyopharm Therapeutics, Inc. Recent Developments
- Table 28. Genentech, Inc. Company Information
- Table 29. Genentech, Inc. Business Overview
- Table 30. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
- Table 31. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- Table 32. Genentech, Inc. Recent Developments
- Table 33. FORMA Therapeutics, Inc. Company Information
- Table 34. FORMA Therapeutics, Inc. Business Overview
- Table 35. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
- Table 36. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
- Table 37. FORMA Therapeutics, Inc. Recent Developments
- Table 38. Calico LLC Company Information
- Table 39. Calico LLC Business Overview
- Table 40. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
- Table 41. Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
- Table 42. Calico LLC Recent Developments
- Table 43. Aurigene Discovery Technologies Limited Company Information
- Table 44. Aurigene Discovery Technologies Limited Business Overview
- Table 45. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
- Table 46. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
- Table 47. Aurigene Discovery Technologies Limited Recent Developments
- Table 48. Angelini Group Company Information
- Table 49. Angelini Group Business Overview
- Table 50. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
- Table 51. Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
- Table 52. Angelini Group Recent Developments
- Table 53. Global Nicotinamide Phosphoribosyltransferase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 54. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2020-2025) & (W Tons)
- Table 55. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2020-2025)
- Table 56. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2026-2031) & (W Tons)
- Table 57. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2026-2031)
- Table 58. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2020-2025) & (US$ Million)
- Table 59. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2020-2025)
- Table 60. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2026-2031) & (US$ Million)
- Table 61. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2026-2031)
- Table 62. North America Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 63. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (W Tons)
- Table 64. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (W Tons)
- Table 65. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
- Table 66. North America Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
- Table 67. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 68. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (W Tons)
- Table 69. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (W Tons)
- Table 70. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
- Table 71. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
- Table 72. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 73. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (W Tons)
- Table 74. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (W Tons)
- Table 75. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
- Table 76. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
- Table 77. South America Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 78. South America Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (W Tons)
- Table 79. South America Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (W Tons)
- Table 80. South America Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
- Table 81. South America Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
- Table 82. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 83. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2020-2025) & (W Tons)
- Table 84. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2026-2031) & (W Tons)
- Table 85. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2020-2025) & (US$ Million)
- Table 86. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2026-2031) & (US$ Million)
- Table 87. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2025) & (W Tons)
- Table 88. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2026-2031) & (W Tons)
- Table 89. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2020-2025)
- Table 90. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2026-2031)
- Table 91. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2025) & (US$ Million)
- Table 92. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2026-2031) & (US$ Million)
- Table 93. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2020-2025)
- Table 94. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2026-2031)
- Table 95. Global Nicotinamide Phosphoribosyltransferase Price by Type (2020-2025) & (US$/Ton)
- Table 96. Global Nicotinamide Phosphoribosyltransferase Price by Type (2026-2031) & (US$/Ton)
- Table 97. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2025) & (W Tons)
- Table 98. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2026-2031) & (W Tons)
- Table 99. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2020-2025)
- Table 100. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2026-2031)
- Table 101. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2025) & (US$ Million)
- Table 102. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2026-2031) & (US$ Million)
- Table 103. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2020-2025)
- Table 104. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2026-2031)
- Table 105. Global Nicotinamide Phosphoribosyltransferase Price by Application (2020-2025) & (US$/Ton)
- Table 106. Global Nicotinamide Phosphoribosyltransferase Price by Application (2026-2031) & (US$/Ton)
- Table 107. Key Raw Materials
- Table 108. Raw Materials Key Suppliers
- Table 109. Nicotinamide Phosphoribosyltransferase Distributors List
- Table 110. Nicotinamide Phosphoribosyltransferase Customers List
- Table 111. Nicotinamide Phosphoribosyltransferase Industry Trends
- Table 112. Nicotinamide Phosphoribosyltransferase Industry Drivers
- Table 113. Nicotinamide Phosphoribosyltransferase Industry Restraints
- Table 114. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Nicotinamide Phosphoribosyltransferase Product Image
- Figure 5. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Nicotinamide Phosphoribosyltransferase Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Nicotinamide Phosphoribosyltransferase Sales (2020-2031) & (W Tons)
- Figure 8. Global Nicotinamide Phosphoribosyltransferase Average Price (US$/Ton) & (2020-2031)
- Figure 9. Lipids Product Image
- Figure 10. Small Molecule Compounds Product Image
- Figure 11. Hormone Product Image
- Figure 12. Others Product Image
- Figure 13. Breast Cancer Product Image
- Figure 14. Parkinson's Disease Product Image
- Figure 15. Acute Lung Injury Product Image
- Figure 16. Others Product Image
- Figure 17. Global Nicotinamide Phosphoribosyltransferase Revenue Share by Manufacturers in 2024
- Figure 18. Global Manufacturers of Nicotinamide Phosphoribosyltransferase, Manufacturing Sites & Headquarters
- Figure 19. Global Top 5 and 10 Nicotinamide Phosphoribosyltransferase Players Market Share by Revenue in 2024
- Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 21. Global Nicotinamide Phosphoribosyltransferase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 22. Global Nicotinamide Phosphoribosyltransferase Sales by Region in 2024
- Figure 23. Global Nicotinamide Phosphoribosyltransferase Revenue by Region in 2024
- Figure 24. North America Nicotinamide Phosphoribosyltransferase Market Size by Country in 2024
- Figure 25. North America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
- Figure 26. North America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
- Figure 27. United States Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 28. Canada Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 29. Europe Nicotinamide Phosphoribosyltransferase Market Size by Country in 2024
- Figure 30. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
- Figure 31. Europe Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
- Figure 32. Germany Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. France Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. U.K. Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Italy Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Netherlands Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Asia Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country in 2024
- Figure 38. Asia Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
- Figure 39. Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
- Figure 40. China Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. Japan Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. South Korea Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. India Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. Australia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. China Taiwan Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. Southeast Asia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. Southeast Asia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. South America Nicotinamide Phosphoribosyltransferase Market Size by Country in 2024
- Figure 49. South America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
- Figure 50. South America Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
- Figure 51. Mexico Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 52. Brazil Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 53. Argentina Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 54. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country in 2024
- Figure 55. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2020-2031)
- Figure 56. Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2020-2031)
- Figure 57. Turkey Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 58. Saudi Arabia Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 59. UAE Nicotinamide Phosphoribosyltransferase Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 60. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2020-2031)
- Figure 61. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2020-2031)
- Figure 62. Global Nicotinamide Phosphoribosyltransferase Price (US$/Ton) by Type (2020-2031)
- Figure 63. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2020-2031)
- Figure 64. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2020-2031)
- Figure 65. Global Nicotinamide Phosphoribosyltransferase Price (US$/Ton) by Application (2020-2031)
- Figure 66. Nicotinamide Phosphoribosyltransferase Value Chain
- Figure 67. Nicotinamide Phosphoribosyltransferase Production Mode & Process
- Figure 68. Direct Comparison with Distribution Share
- Figure 69. Distributors Profiles
- Figure 70. Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
